Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Drug Resistance

  Free Subscription


1 Antimicrob Agents Chemother
2 Clin Infect Dis
4 Infect Control Hosp Epidemiol
1 J Infect Chemother
5 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Antimicrob Agents Chemother

  1. MELETIADIS J, Turlej-Rogacka A, Lerner A, Adler A, et al
    Erratum for Meletiadis et al., "Amplification of Antimicrobial Resistance in Gut Flora of Patients Treated with Ceftriaxone".
    Antimicrob Agents Chemother. 2018;62.
    PubMed     Text format    

    Clin Infect Dis

    Do We Need Another Study to Control Carbapenem-resistant Organisms, or Do We Just Need to Get Better at the Basics?
    Clin Infect Dis. 2018 Nov 23. pii: 5201668. doi: 10.1093.
    PubMed     Text format    

  3. TOMCZYK S, Zanichelli V, Grayson ML, Twyman A, et al
    Control of Carbapenem-resistant Enterobacteriaceae, Acinetobacter baumannii, and Pseudomonas aeruginosa in Healthcare Facilities: A Systematic Review and Reanalysis of Quasi-experimental Studies.
    Clin Infect Dis. 2018 Nov 23. pii: 5201688. doi: 10.1093.
    PubMed     Text format     Abstract available

    Infect Control Hosp Epidemiol

  4. CADNUM JL, Shaikh AA, Piedrahita CT, Jencson AL, et al
    Relative Resistance of the Emerging Fungal Pathogen Candida auris and Other Candida Species to Killing by Ultraviolet Light.
    Infect Control Hosp Epidemiol. 2018;39:94-96.
    PubMed     Text format     Abstract available

  5. CHANDY M, Das A, Bhattacharyya A, Banerjee S, et al
    Colistin-Resistant Klebsiella Infections Among Pediatric Oncology and Hematopoietic Stem Cell Transplantation Patients in Eastern India.
    Infect Control Hosp Epidemiol. 2018;39:118-121.
    PubMed     Text format    

  6. LI DX, Sick-Samuels AC, Suwantarat N, Same RG, et al
    Risk Factors for Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae Carriage Upon Pediatric Intensive Care Unit Admission.
    Infect Control Hosp Epidemiol. 2018;39:116-118.
    PubMed     Text format    

  7. BURNHAM JP, Kwon JH, Olsen MA, Babcock HM, et al
    Readmissions With Multidrug-Resistant Infection in Patients With Prior Multidrug Resistant Infection.
    Infect Control Hosp Epidemiol. 2018;39:12-19.
    PubMed     Text format     Abstract available

    J Infect Chemother

  8. HUANG W, Cheng Y, Li X, Tan M, et al
    Neuraminidase inhibitor susceptibility profile of human influenza viruses during the 2016-2017 influenza season in Mainland China.
    J Infect Chemother. 2018;24:729-733.
    PubMed     Text format     Abstract available

    PLoS One

  9. VAN RIJT AM, Dik JH, Lokate M, Postma MJ, et al
    Cost analysis of outbreaks with Methicillin-resistant Staphylococcus aureus (MRSA) in Dutch long-term care facilities (LTCF).
    PLoS One. 2018;13:e0208092.
    PubMed     Text format     Abstract available

  10. JAJOO M, Manchanda V, Chaurasia S, Sankar MJ, et al
    Alarming rates of antimicrobial resistance and fungal sepsis in outborn neonates in North India.
    PLoS One. 2018;13:e0180705.
    PubMed     Text format     Abstract available

  11. KIGOZI E, Kasule GW, Musisi K, Lukoye D, et al
    Prevalence and patterns of rifampicin and isoniazid resistance conferring mutations in Mycobacterium tuberculosis isolates from Uganda.
    PLoS One. 2018;13:e0198091.
    PubMed     Text format     Abstract available

  12. MO SS, Urdahl AM, Madslien K, Sunde M, et al
    What does the fox say? Monitoring antimicrobial resistance in the environment using wild red foxes as an indicator.
    PLoS One. 2018;13:e0198019.
    PubMed     Text format     Abstract available

  13. ROSNER S, Gehlweiler K, Kusters U, Kolbert M, et al
    Comparison of two commercial carbapenemase gene confirmatory assays in multiresistant Enterobacteriaceae and Acinetobacter baumannii-complex.
    PLoS One. 2018;13:e0197839.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Drug Resistance is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.